Browsing by subject "Solid tumors"
Now showing items 1-1 of 1
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors. (2017-01)PURPOSE: The combination of afatinib, an irreversible ErbB family blocker, with paclitaxel and bevacizumab was assessed in patients with advanced solid tumors. METHODS: This phase I study used a 3 + 3 design to determine ...